Introduction {#sec1-1}
============

The liver is the second largest organ in the body, and is often seen as the most important one. The liver receives a dual blood supply with about 20% of blood coming from the hepatic artery and 80% from the portal circulation. The blood flow to the liver is around 20 to 25% of the total cardiac output. Toxins, infectious agents, medications, and serum inflammatory mediators may result in a diverse range of disease processes, leading to loss of normal histological architecture, reduced cell mass, and loss of blood flow. Consequently, functional liver capacity may be lost. Efforts have been made to search for effective hepatoprotective agents. However, no effective hepatoprotective therapies are available until now. Therefore, the prevention of liver diseases has a great significance both in theory and in practice.\[[@ref1]\] Herbal drugs play a major role in the treatment of hepatic disorders. In the absence of reliable hepatoprotective drugs in modern medicine, a number of medicinal plants and their formulations are used to cure hepatic disorders in traditional systems of medicine in India.\[[@ref2]\]

Several plants of the family Asclepiadaceae consisting of flavonoids like rutin, silymarin, and quercetin have been reported to possess a hepatoprotective potential.\[[@ref3]--[@ref5]\] Hence, it was decided to evaluate whether this activity could be related to this family. In this study, stems of *Leptadenia reticulata* (Retz.) Wight. and Arn. (Jivanti) were investigated for the hepatoprotective activity against carbon tetrachloride (CCl~4~)-induced toxicity.

*L. reticulata* plant is a twining shrub that grows in sub-himalayan tracts of Punjab, Gujarat, Uttar Pradesh, and throughout peninsular India, ascending up to an altitude of 900 m. According to Ayurveda, jivanti is jeevana tonic that boost energy level of the body. It is mainly indicated for those who suffer from weak debility or a lack of energy. It is a cooling, mucilaginous, demulcent herb with light strengthening and tonic properties traditionally used in the treatment of seminal discharges and snake bite.\[[@ref6]--[@ref8]\] A number of studies have been carried out on the plant for its antioxidant, galactagogue, antibacterial, lactogenic, antifungal, hypotensive, restorative, tonic, and stimulant activities.\[[@ref9][@ref10]\]

The plant contains a triterpenoid, leptadenol, α-amyrin, β-amyrin, ferulic acid, luteolin, diosmetin, rutin, β-sitosterol, stigmasterol, hentriacontanol, a triterpene alcohol simiarenol, and apigenin in significant amounts.\[[@ref11][@ref12]\] It also contains pregnane glycosides such as reticulin, deniculatin, and leptaculatin isolated from aerial parts which on hydrolysis give calogenin tocopherols.\[[@ref13][@ref14]\] The antioxidant activity of *L. reticulata* is due to its flavonoid contents like apigenin, rutin, and luteolin. Hence, it is implicit that they might be used as hepatoprotective agents also.

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Chemicals {#sec3-1}

All chemicals used were of analytical grade. The kits for the estimation of serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), total bilirubin (TB), and total protein were purchased from Beacon Diagnostic Pvt. Ltd. Kabilpore and Loba Chemicals, Mumbai.

### Plant Collection and Extraction {#sec3-2}

The stems of *L. reticulata* (Retz.) were purchased from the local market of Sagar (M.P.) in the month of November 2009 and were identified and authenticated in Department of Botany, Dr. H. S. Gour University, Sagar. A voucher specimen (MPY-LR01) was deposited in the Pharmacognosy Division, Sagar Institute of Pharmaceutical Sciences, Sagar (M.P.).

Stems of *L. reticulata* were dried under shade, powdered with a mechanical grinder, and passed through sieve no. 40. The sieved powder was stored in airtight container and kept in room temperature. Dried plant material (500 g) was extracted with Soxhlet apparatus using petroleum ether for about 48 hours. After defatting, the marc was dried in hot air oven at 50°C, packed in Soxhlet apparatus, and further extracted with 95% ethanol exhaustively. The aqueous extract was prepared by cold maceration (72 hours). The solvents were removed from the extracts under reduced pressure by using rotary vacuum evaporator.

### Animal Studies {#sec3-3}

Acute toxicity studies were performed according to Organization for Economic Co-Operation and Development (OECD)-423 guidelines.\[[@ref15]\] Male Swiss mice selected by random sampling technique were used. The animals were fasted for 3 hours with free access to water only. *L. reticulata* extracts were administered orally at a dose of 5 mg/kg initially. Mortality was observed for 2 days. If mortality was observed in two of three animals, then the dose administered was considered as toxic dose. However, if no mortality was observed, the procedure was repeated for further higher dose such as 50, 300, and 2 000 mg / kg body weight. The animals were observed for toxic symptoms such as behavioral changes, locomotion, convulsion, and mortality for 24 hours. Two sub-maximal doses 1/10^th^ cut-off dose for extracts 250 and 500 mg/kg, p.o. were found to be safe (1/10^th^ of LD~50~) and used for further pharmacological investigations.

Wistar albino rats (150-200 g) were used for all other studies, and they were housed at a temperature of 24 ± 2°C at a relative humidity of 50% maintained on 12-hour light/dark cycle and allowed food and water *ad libitum*. Study was conducted after obtaining a clearance from the Institutional Animal Ethics Committee (Reg. No. 1252/AC/09/CPCSEA) of Bansal College of Pharmacy, Bhopal (M.P.).

Animals were randomly divided into seven groups of six animals each. Group I served as control and received normal saline. Group II served as toxic control and received 1 : 1 (v/v) mixture of CCl~4~ in olive oil at a dose of 1.25 ml/kg, p.o (for 7 days). Group III served as standard group and received silymarin (50 mg/kg), while Groups IV and V were treated with ethanolic extract of *L. reticulata* at the dose of 250 and 500 mg/kg/day, p.o. for 7 days, respectively. Groups VI and VII were treated with aqueous extract of *L. reticulata* at the dose of 250 and 500 mg/kg/day, p.o. for 7 days, respectively.

Twenty-four hours after CCl~4~ treatment (Day 8), all the animals were sacrificed under light ether anesthesia. Blood was collected from the retro-orbital plexus of all the rats and allowed to coagulate for 30 minutes at 37°C. Serum was separated by centrifugation at 2 500 rpm at 37°C for 15 minutes and analyzed for SGOT, SGPT, ALP, TB, and total protein.\[[@ref16]--[@ref20]\]

### Histopathological Studies {#sec3-4}

After draining the blood, liver samples were excised, washed with normal saline, and processed separately for histological observations. Initially, the material was fixed in 10% buffered neutral formalin for 48 hours. The sections were cut in 5-mm thickness, stained with hematoxylin and eosin, and examined microscopically for histopathological changes.

### Statistical Analysis {#sec3-5}

All the results were expressed as mean ± SEM. One-way Analysis of Variance (ANOVA) was used for the statistical analysis of data. Dunnett\'s multiple comparison test\[[@ref21]\] was used for determining the significance. A probability value of *P*\<0.05 was considered as significant.

Results {#sec1-3}
=======

The administration of CCl~4~ to the animals resulted in a marked increase (*P*\<0.01) in TB, serum amino transaminases (SGOT and SGPT), and serum ALP. The serum total protein level was decreased when compared with Group I (vehicle control) \[[Table 1](#T1){ref-type="table"}\]. The oral administration of alcoholic and aqueous extracts of *L. reticulata* and silymarin reduced the CCl~4~-induced increase in the SGOT, SGPT, and TB levels (*P*\<0.01). The extracts also reversed the depletion of total protein significantly (*P*\<0.05 and *P*\<0.01, respectively) when compared with Group II (CCl~4~-treated group).

###### 

Effect of *L. reticulata* stems extracts on CCl~4~-induced hepatotoxicity in rats
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The toxic effect of CCl~4~ was controlled in the animals treated with the extracts by way of restoration of the levels of the liver function biochemistry similar to that of the standard drug silymarin. Among the extract-treated groups, significant hepatoprotective activity was observed.

In the histopathological studies, the liver sections of rats treated with vehicle showed normal hepatic architecture \[[Figure 1](#F1){ref-type="fig"}\], whereas that of CCl~4~-treated group showed total loss of hepatic architecture with intense peripheral central vein necrosis, fatty changes, congestion of sinusoids, Kupffer cell hyperplasia, crowding of the central vein, and apoptosis \[[Figure 2](#F2){ref-type="fig"}\]. In case of rats treated with silymarin \[[Figure 3](#F3){ref-type="fig"}\] and *L. reticulata* alcoholic extract 250 mg/kg \[[Figure 4](#F4){ref-type="fig"}\] and 500 mg/kg \[[Figure 5](#F5){ref-type="fig"}\], respectively, a normal hepatic architecture was seen with only moderate accumulation of fatty lobules and mild degree of cell necrosis, clearly indicating the protection offered by standard drug silymarin and the plant extract.
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Discussion {#sec1-4}
==========

CCl~4~ is commonly used for induction of experimental liver toxicity. This toxic chemical causes peroxidative degradation in the adipose tissue, resulting in fatty infiltration of the hepatocytes. Its metabolites such as trichloromethyl radical (CCl~3~) and trichloromethyl peroxy radical (CCl~3~O~2~) are involved in the pathogenesis of liver. As shown in [Figure 2](#F2){ref-type="fig"}, CCl~4~ causes change around the central vein in the liver and other oxidative damages with the leakage of marker enzymes like SGOT, SGPT, and ALP in the serum, increase in serum TB levels and decrease in serum total protein.\[[@ref22][@ref23]\]

Administration of ethanolic and aqueous extracts of *L. reticulata* stems showed significant hepatoprotective activity, which was comparable with the standard drug silymarin. The effect was more pronounced with ethanolic extract. The qualitative phytochemical investigations on the ethanolic extract of *L. reticulata* also showed positive for flavonoids by ferric chloride, alkaline reagent, and Shinoda tests. Furthermore, it has been reported that the flavonoid constituents of plant possess antioxidant properties\[[@ref24]\] and was found to be useful in the treatment of liver damage.

Earlier works have reported the presence of flavonoids, alkaloids, saponins, and glycosides in the alcoholic extract. The results indicate that the ethanolic extract of *L. reticulata* has significant hepatoprotective activity. This may be probably due to the higher content of flavonoids like luteolin, rutin, and apigenin. The earlier investigators\[[@ref25]\] have screened the hepatoprotective activity of the flavonoid compound, rutin, which is also claimed to have free radical scavenging property and it inhibits the lipid peroxidation against CCl~4~-induced hepatic toxicity. The isolation and characterization of the flavonoids from the stem bark of *L. reticulata* and screening of the pharmacological action against the liver damage is being investigated.

The results of the present study suggest that alcoholic and aqueous extracts of *L. reticulata* stems have significant hepatoprotective activity and alcoholic extract offers a greater hepatoprotection than the aqueous.

**Source of Support:** Nil.

**Conflict of Interest:** None declared.
